Why is Wave Life Sciences Ltd. ?
1
Flat results in Sep 25
- OPERATING CASH FLOW(Y) Lowest at USD -199.59 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 21.17%, its profits have risen by 14.4%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wave Life Sciences Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Wave Life Sciences Ltd.
15.49%
0.59
164.73%
S&P 500
13.68%
0.84
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
52.97%
EBIT Growth (5y)
4.49%
EBIT to Interest (avg)
-120.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.31
Sales to Capital Employed (avg)
1.30
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
17.64
EV to EBIT
-15.80
EV to EBITDA
-16.89
EV to Capital Employed
-38.78
EV to Sales
19.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-92.09%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
5What is working for the Company
NET SALES(HY)
At USD 16.31 MM has Grown at 35.71%
NET PROFIT(HY)
Higher at USD -104.32 MM
RAW MATERIAL COST(Y)
Fallen by -7,069% (YoY
-3What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -199.59 MM
Here's what is working for Wave Life Sciences Ltd.
Net Sales
At USD 16.31 MM has Grown at 35.71%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
Higher at USD -104.32 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Raw Material Cost
Fallen by -7,069% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 2.23 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Wave Life Sciences Ltd.
Operating Cash Flow
Lowest at USD -199.59 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)






